Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
for
Primary Membranous Nephropathy
Location: Los Angeles CA, Tarzana CA, Las Vegas NV, Surprise AZ,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07204275
Phase 2, Phase 3, Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
for
Diabetic Nephropathies,
Location: Los Angeles CA, Denver CO, San Antonio TX,
Sponsor: Walden Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06466135
Phase 2, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Huntington Park CA, Sherman Oaks CA, Tucson AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06855160
Phase 3, Recruiting
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
for
Primary Membranous Nephropathy
Location: Los Angeles CA, San Dimas CA, Tarzana CA, Houston TX,
Sponsor: Cerium Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05696613
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Los Angeles CA, Palm Springs CA, San Diego CA,
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
for
Glomerulonephritis, Membranous
Location: Los Angeles CA, Doral FL, Miami FL, Pembroke Pines FL
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07851220
Phase 3, Recruiting
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning